Search

Displaying results 7541 - 7550 of 10000 in total
  1. Indication

    Carbuncle

    go.drugbank.com/conditions/DBCOND0000041
    Drugs: Diphenylpyraline · Neomycin
    Synonyms: Carbuncle NOS (disorder)
  2. Indication

    Malignant Hypertension

    go.drugbank.com/conditions/DBCOND0040156
    Drugs: Fenoldopam
    Synonyms: Malignant hypertension NOS
  3. Indication

    Specific infections by free-living amoebae

    go.drugbank.com/conditions/DBCOND0089199
    Drugs: Miltefosine
    Synonyms: Amebiasis NOS, Amoebiasis NOS
  4. Drug

    DOTMP HO-166

    go.drugbank.com/drugs/DB05380
    Experimental

    It is an experimental therapy that is being developed by NeoRx Corporation.

  5. Indication

    Sodium retention

    go.drugbank.com/conditions/DBCOND0015831
    Drugs: Hydrochlorothiazide
    Synonyms: Hypernatremia, NOS, Hypernatraemia, NOS
  6. Indication

    Epiphora

    go.drugbank.com/conditions/DBCOND0034135
    Drugs: Chlorpheniramine · Choline salicylate · Loratadine · Pholcodine
    Synonyms: Epiphora, NOS, Illacrimation, NOS
  7. Indication

    Vision Disorders

    go.drugbank.com/conditions/DBCOND0035879
    Drugs: Almitrine · Faricimab · Ranibizumab
    Synonyms: Vision disorder, NOS, Vision abnormal NOS
  8. Drug

    TAS-102

    go.drugbank.com/drugs/DB08937
    Investigational

    Trifluridine inhibits tumor growth by being incorporated into DNA during DNA synthesis. Tipiracil prevents trifluridine from being broken down when taken orally.

  9. Drug

    Candoxatrilat

    go.drugbank.com/drugs/DB11623
    Experimental

    A dicarboxylic acid monoamide obtained by formal condensation between the amino group of cis-4-aminocyclohexanecarboxylic acid and the cyclopentanecarboxylic acid group of 1-[(2S)-2-carboxy-3-(2-methoxyethoxy

  10. Drug

    PMI-001

    go.drugbank.com/drugs/DB05730
    Experimental

    PMI-001 is a stand-alone, disease-modifying, anti-rheumatic drug (DMARD) being developed by Phytomedics Inc.